We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Fujifilm Europe GmbH

Fujifilm is a pioneer in diagnostic imaging and information systems for healthcare facilities and offers clinically p... read more Featured Products: More products

Download Mobile App





Fujifilm Medical Systems Europe Highlights AI Initiative in Austria

By MedImaging International staff writers
Posted on 28 Feb 2019
Print article
Image: With REiLI, Fujifilm is developing a technology to accurately recognize and consistently extract organ regions, regardless of deviations in shape, presence or absence of disease, and imaging conditions (Photo courtesy of Fujifilm Medical Systems).
Image: With REiLI, Fujifilm is developing a technology to accurately recognize and consistently extract organ regions, regardless of deviations in shape, presence or absence of disease, and imaging conditions (Photo courtesy of Fujifilm Medical Systems).
Fujifilm Medical Systems Europe (Düsseldorf, NRW) celebrated SYNAPSE 20 years anniversary and presented REiLI, the company's global Medical Imaging and Informatics Artificial Intelligence (AI) technology initiative, at the European Congress of Radiology (ECR) annual meeting held from February 27th to March 3rd, 2019 at Austria Congress Center in Vienna, Austria. At FUJIFILM’s in-booth AI Center, visitors were offered live demonstrations of AI delivering enhanced workflows.

Under the REiLI brand, Fujifilm is developing AI technologies that strongly support diagnostic imaging workflow, leveraging the combination of deep learning in its AI technology with the company’s image processing heritage. The applications currently under development include: Region Recognition, an AI technology to accurately recognize and consistently extract organ regions, regardless of deviations in shape, presence or absence of disease, and imaging conditions; Computer Aided Detection, an AI technology to reduce the time of image interpretation and support radiologists' clinical decision making; Workflow Support, using AI technology to realize optimal study prioritization, alert communications of AI findings, and report population automation.

Fujifilm Healthcare’s IT platform showcased at ECR 2019 included its comprehensive medical informatics and enterprise-imaging portfolio, such as SYNAPSE 5, the next generation PACS and one of the fastest medical imaging solutions in the industry, offering sub second delivery of extremely large datasets; SYNAPSE VNA, the most secure, comprehensive application for storing and providing access to the complete imaging records; SYNAPSE MOBILITY Enterprise Viewer which uses the latest server-side rendering technology to stream imaging securely and quickly to any authorized user; SYNAPSE 3D, an enterprise-wide solution for quickly accessing 3D images and designed for use across multiple specialties, including radiology, cardiology, surgery and more; SYNAPSE CWM, a Clinical Workflow Manager and the most advanced radiology information system on the market today; and SYNCRO-DOSE, a radiation dose index monitoring system that is compliant with the Directive 2013/59/EURATOM of the European Union.

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Silver Member
Mobile X-Ray Barrier
Lead Acrylic Mobile X-Ray Barriers
New
Ultrasound System
P20 Elite
New
Wireless Handheld Ultrasound System
TE Air

Print article
Radcal

Channels

MRI

view channel
Image: The emerging role of MRI alongside PSA testing is redefining prostate cancer diagnostics (Photo courtesy of 123RF)

Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients

Prostate cancer is a leading health concern globally, consistently being one of the most common types of cancer among men and a major cause of cancer-related deaths. In the United States, it is the most... Read more

Nuclear Medicine

view channel
Image: The new SPECT/CT technique demonstrated impressive biomarker identification (Journal of Nuclear Medicine: doi.org/10.2967/jnumed.123.267189)

New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access

The development of lead-212 (212Pb)-PSMA–based targeted alpha therapy (TAT) is garnering significant interest in treating patients with metastatic castration-resistant prostate cancer. The imaging of 212Pb,... Read more

General/Advanced Imaging

view channel
Image: The Tyche machine-learning model could help capture crucial information. (Photo courtesy of 123RF)

New AI Method Captures Uncertainty in Medical Images

In the field of biomedicine, segmentation is the process of annotating pixels from an important structure in medical images, such as organs or cells. Artificial Intelligence (AI) models are utilized to... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.